Economic Evaluation of Tobramycin Inhalation Powder for the Treatment of Chronic Pulmonary Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis

von Panguluri, Srilekha, Gunda, Praveen, Debonnett, Laurie, Hamed, Kamal
Veröffentlicht in Clin Drug Investig (2017)

Cost-effectiveness of secukinumab compared to other biologics in the treatment of ankylosing spondylitis in Finland

von Purmonen, Timo, Puolakka, Kari, Mishra, Dinesh, Gunda, Praveen, Martikainen, Janne
Veröffentlicht in Clinicoecon Outcomes Res (2019)

Cost Effectiveness of Secukinumab for the Treatment of Active Psoriatic Arthritis in the UK

von Buchanan, Vanessa, Sullivan, Will, Graham, Chris, Miles, LaStella, Jugl, Steffen Marc, Gunda, Praveen, Halliday, Anna, Kirkham, Bruce
Veröffentlicht in Pharmacoeconomics (2018)

Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative

von Colombo, Giorgio L, Di Matteo, Sergio, Martinotti, Chiara, Jugl, Steffen M, Gunda, Praveen, Naclerio, Mariantonietta, Bruno, Giacomo M
Veröffentlicht in Clinicoecon Outcomes Res (2018)

Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK

von Emery, Paul, Van Keep, Marjolijn, Beard, Steve, Graham, Chris, Miles, LaStella, Jugl, Steffen Marc, Gunda, Praveen, Halliday, Anna, Marzo-Ortega, Helena
Veröffentlicht in Pharmacoeconomics (2018)